Abzena and BioXpress Therapeutics announce partnership to support the development and manufacture of biosimilars for global customers.

Abzena's partnership with BioXpress will allow biosimilar drug developers to benefit from an integrated approach to biosimilars spanning the range from design consultancy, cell line and process development, through to clinical and commercial GMP manufacture.

Read More

Watch our webinars on demand!

If you'd like to expand your knowledge on a range of topics from antibody development to pre-formulation, our webinars, hosted by our team of experts, are now available for you on demand.

Watch now

Abzena announces location of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

The significant expansion of Abzena’s capacity is driven by an increase in customer demand for commercial scale 2000L single use bioreactors across a wide range of therapeutic areas.

Read More

The Leading Biologics Target to GMP Partner Research Organisation

Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and ADC drug development services in the pharmaceutical industry.

About Us Contact Us

Technologies and Solutions

Abzena provides proprietary technologies and complementary solutions to organisations involved in the development of biopharmaceutical products.

Latest News and Events

Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.

Load More

Resources and Downloads

Find our latest videos, brochures and fact sheets in our resources section.

Download our Brochure

Technology & Solutions Brochure

Download File

Stability of Maleimide-PEG and Mono-Sulfone-PEG Conjugation to a Novel Engineered Cysteine in the Human Hemoglobin Alpha Subunit

In order to use a Hemoglobin Based Oxygen Carrier as an oxygen therapeutic or blood…

Read More

Cell Line Development Lab Tour

Abzena has over 10 years experience in Cell Line Development for customers and has completed…

View All Resources